Charles River Laboratories is a leading drug discovery and non-clinical development company. As an essential partner to the biopharmaceutical industry, the company serves a critical function in the drug development process, collaborating with clients from the earliest stages of target identification, through the drug safety testing process and all the way through market approval.
Building upon its history of laboratory animal science, Charles River Laboratories delivers comprehensive, outsourced drug discovery and safety assessment services, as well as manufacturing solutions from biologics production to microbial testing—working with clients to identify, understand, and distinguish viable molecules from those that are not, making the company the bridge between biopharmaceutical companies and the patients who need critical therapies.
Charles River Laboratories was founded in 1947.
The company’s corporate offices are located at 251 Ballardvale Street, Wilmington, Massachusetts, USA.
Charles River Laboratories initially went public in 1968 on the NASDAQ and was later bought by Bausch & Lomb in 1984. In September 1999, the executive management team completed a leveraged buyout of the company. In June 2000, the company launched an initial public offering and again became a public company. It trades on the New York Stock Exchange under the ticker symbol “CRL.”
Charles River Laboratories has global operations in approximately 120 locations in 20 countries, including a significant presence in North America, Europe, and Asia.
The company has approximately 20,000 employees worldwide.
This information can be found on the “Corporate Governance” section of our website.
PricewaterhouseCoopers LLP
101 Seaport Boulevard, Suite 500
Boston, MA 02210
(617) 530-5000
First Class/Registered/Certified Mail:
Computershare Investor Services
PO BOX 43101
Providence RI 02940-3101
(877) 282-1168
www.computershare.com/investor
Courier Services:
Computershare Investor Services
150 Royall Street, Suite 101
Canton, MA 02021
Go to the “Email Alerts” or "Contact Information" pages of our website.